Pathobiology of ALK-negative anaplastic large cell lymphoma

Stefano A. Pileri, Claudio Agostinelli, Francesco Bacci, Elena Sabattini, Carlo Sagramoso, Brunangelo Falini, Pier Paolo Piccaluga

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The authors revise the concept of ALK-negative anaplastic large cell lymphoma (ALCL) in the light of the recently updated WHO classification of Tumors of Hematopoietic and Lymphoid Tissues both on biological and clinical grounds. The main histological findings are illustrated as well as the phenotypic, molecular and clinical characteristics. Finally, the biological rationale for possible innovative targeted therapies is presented.

Original languageEnglish
Article numbere5
Pages (from-to)8-10
Number of pages3
JournalPediatric Reports
Volume3
Issue number2S
DOIs
Publication statusPublished - 2011

Fingerprint

Anaplastic Large-Cell Lymphoma
Investigational Therapies
Lymphoid Tissue
Neoplasms

Keywords

  • ALK-negative
  • Anaplastic
  • Cell
  • Large
  • Lymphoma

ASJC Scopus subject areas

  • Pediatrics

Cite this

Pileri, S. A., Agostinelli, C., Bacci, F., Sabattini, E., Sagramoso, C., Falini, B., & Piccaluga, P. P. (2011). Pathobiology of ALK-negative anaplastic large cell lymphoma. Pediatric Reports, 3(2S), 8-10. [e5]. https://doi.org/10.4081/pr.2011.s2.e5

Pathobiology of ALK-negative anaplastic large cell lymphoma. / Pileri, Stefano A.; Agostinelli, Claudio; Bacci, Francesco; Sabattini, Elena; Sagramoso, Carlo; Falini, Brunangelo; Piccaluga, Pier Paolo.

In: Pediatric Reports, Vol. 3, No. 2S, e5, 2011, p. 8-10.

Research output: Contribution to journalArticle

Pileri, SA, Agostinelli, C, Bacci, F, Sabattini, E, Sagramoso, C, Falini, B & Piccaluga, PP 2011, 'Pathobiology of ALK-negative anaplastic large cell lymphoma', Pediatric Reports, vol. 3, no. 2S, e5, pp. 8-10. https://doi.org/10.4081/pr.2011.s2.e5
Pileri SA, Agostinelli C, Bacci F, Sabattini E, Sagramoso C, Falini B et al. Pathobiology of ALK-negative anaplastic large cell lymphoma. Pediatric Reports. 2011;3(2S):8-10. e5. https://doi.org/10.4081/pr.2011.s2.e5
Pileri, Stefano A. ; Agostinelli, Claudio ; Bacci, Francesco ; Sabattini, Elena ; Sagramoso, Carlo ; Falini, Brunangelo ; Piccaluga, Pier Paolo. / Pathobiology of ALK-negative anaplastic large cell lymphoma. In: Pediatric Reports. 2011 ; Vol. 3, No. 2S. pp. 8-10.
@article{10cab643b97b43dd802797b7ab9acf5d,
title = "Pathobiology of ALK-negative anaplastic large cell lymphoma",
abstract = "The authors revise the concept of ALK-negative anaplastic large cell lymphoma (ALCL) in the light of the recently updated WHO classification of Tumors of Hematopoietic and Lymphoid Tissues both on biological and clinical grounds. The main histological findings are illustrated as well as the phenotypic, molecular and clinical characteristics. Finally, the biological rationale for possible innovative targeted therapies is presented.",
keywords = "ALK-negative, Anaplastic, Cell, Large, Lymphoma",
author = "Pileri, {Stefano A.} and Claudio Agostinelli and Francesco Bacci and Elena Sabattini and Carlo Sagramoso and Brunangelo Falini and Piccaluga, {Pier Paolo}",
year = "2011",
doi = "10.4081/pr.2011.s2.e5",
language = "English",
volume = "3",
pages = "8--10",
journal = "Pediatric Reports",
issn = "2036-749X",
publisher = "PagePress",
number = "2S",

}

TY - JOUR

T1 - Pathobiology of ALK-negative anaplastic large cell lymphoma

AU - Pileri, Stefano A.

AU - Agostinelli, Claudio

AU - Bacci, Francesco

AU - Sabattini, Elena

AU - Sagramoso, Carlo

AU - Falini, Brunangelo

AU - Piccaluga, Pier Paolo

PY - 2011

Y1 - 2011

N2 - The authors revise the concept of ALK-negative anaplastic large cell lymphoma (ALCL) in the light of the recently updated WHO classification of Tumors of Hematopoietic and Lymphoid Tissues both on biological and clinical grounds. The main histological findings are illustrated as well as the phenotypic, molecular and clinical characteristics. Finally, the biological rationale for possible innovative targeted therapies is presented.

AB - The authors revise the concept of ALK-negative anaplastic large cell lymphoma (ALCL) in the light of the recently updated WHO classification of Tumors of Hematopoietic and Lymphoid Tissues both on biological and clinical grounds. The main histological findings are illustrated as well as the phenotypic, molecular and clinical characteristics. Finally, the biological rationale for possible innovative targeted therapies is presented.

KW - ALK-negative

KW - Anaplastic

KW - Cell

KW - Large

KW - Lymphoma

UR - http://www.scopus.com/inward/record.url?scp=84874417869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874417869&partnerID=8YFLogxK

U2 - 10.4081/pr.2011.s2.e5

DO - 10.4081/pr.2011.s2.e5

M3 - Article

AN - SCOPUS:84874417869

VL - 3

SP - 8

EP - 10

JO - Pediatric Reports

JF - Pediatric Reports

SN - 2036-749X

IS - 2S

M1 - e5

ER -